Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04534972 · ClinicalTrials.gov registry record · Phase 3
Strategy to Avoid Excessive Oxygen in Major Burn Patients
A Phase 3 study of Critical Illness and Pathologic Processes, sponsored by University of Colorado, Denver.
- Active
- Registry status
- Phase 3
- Development phase
- 2,000
- Enrollment target
- 6
- Study locations
NCT04534972 is a Phase 3 study of Critical Illness and Pathologic Processes that is active but no longer recruiting, run by University of Colorado, Denver. The registered enrollment target is 2,000 participants, below the 3,116-participant average among 91 other Critical Illness trials with a reported enrollment target (36% lower). The trial reports 6 study locations across 6 states.
The verdict
NCT04534972, a Phase 3 study of Critical Illness and Pathologic Processes, is active but no longer recruiting, sponsored by University of Colorado, Denver.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 3
- Development phase
- 2,000 participants
- Enrollment target
- 6
- Study locations
Study Summary
The objective is to determine the effectiveness of a multimodal educational intervention to reduce supplemental oxygen use in major burn patients. Investigators will also evaluate the safety and clinical effectiveness of the more targeted use of oxygen therapy.
Conditions Studied
Interventions
- OTHER Targeting Normoxemia (SpO2 90-96%; PaO2 60-100 mmHg)
Study Locations (6)
Alabama
- University of Alabama-Birmingham Medical Center - Birmingham
Colorado
- University of Colorado - Aurora
Ohio
- University of Cincinnati Medical Center - Cincinnati
Pennsylvania
- University of Pittsburgh Medical Center - Pittsburgh
Tennessee
- Vanderbilt University Medical Center - Nashville
Texas
- Army Institute of Surgical Research - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2021-04-15 |
| Est. Completion | 2025-12-31 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04534972
The ClinicalTrials.gov registry entry for NCT04534972 describes a study currently listed as active not recruiting, categorized as Phase 3. The registered enrollment target is 2,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,116-participant average among 91 other Critical Illness trials with a reported enrollment target (36% lower). The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Critical Illness appearing as the primary indexed condition, and to 1 intervention - of which Targeting Normoxemia (SpO2 90-96%; PaO2 60-100 mmHg) is the first listed.
NCT04534972 reports 6 study locations spanning 6 distinct geographic areas - top geographies include Alabama, Colorado, Ohio.
Frequently Asked Questions
What is clinical trial NCT04534972 about?
NCT04534972 is a clinical study titled "Strategy to Avoid Excessive Oxygen in Major Burn Patients". The objective is to determine the effectiveness of a multimodal educational intervention to reduce supplemental oxygen use in major burn patients. Investigators will also evaluate the safety and clinical effectiveness of the more targeted use of oxygen therapy.
What is the current status of trial NCT04534972?
This trial is currently active not recruiting. It is a Phase 3 study. The enrollment target is 2,000 participants. The study started on 2021-04-15. Estimated completion is 2025-12-31.
What conditions does trial NCT04534972 study?
This clinical trial studies the following conditions: Critical Illness, Pathologic Processes, Wounds and Injury, Disease Attributes.
What interventions are being tested in trial NCT04534972?
The interventions under investigation include: Targeting Normoxemia (SpO2 90-96%; PaO2 60-100 mmHg) (OTHER).
Who is sponsoring clinical trial NCT04534972?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04534972 being conducted?
This trial has 6 study locations across Alabama, Colorado, Ohio, Pennsylvania, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Critical Illness
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Goal-Directed Sedation in Mechanically Ventilated Infants and Children
RECRUITING · Phase 3
-
Strategy to Avoid Excessive Oxygen for Critically Ill Trauma Patients
ACTIVE NOT RECRUITING · Phase 3
-
Supplemental Enteral Protein in Critical Illness
COMPLETED · Phase 3
-
Efficacy and Mechanisms of GLN Dipeptide in the SICU
COMPLETED · Phase 3
-
Oral Care to Reduce Mouth and Throat Infections in Critically Ill Patients
COMPLETED · Phase 3
-
Preoperative Fasting vs. Not Fasting in Critically Ill Patients
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.